Rare diseases
Investigational molecules
Locations
Back to Germany649 clinical trials in Langenau, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effects of Latozinemab for Patients with Frontotemporal Dementia Due to Progranulin Gene Mutations
GermanyStudy on the Effectiveness of Bortezomib, Rituximab, and Ibrutinib for Patients with Newly Diagnosed Waldenström’s Macroglobulinemia
GermanyStudy Comparing CPX-351 and Conventional Drug Combination for Patients with High-Risk Myelodysplastic Syndromes and Oligoblastic Acute Myeloid Leukemia Before Stem Cell Transplant
GermanyStudy on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis
GermanyStudy of Tucidinostat and Nivolumab for Patients with Advanced Melanoma Not Treated with PD-1 or PD-L1 Inhibitors
GermanyStudy on Brigatinib, Ceritinib, and Alectinib for Patients with Advanced ALK+ Non-Small Cell Lung Cancer
GermanyStudy of Fedratinib and Nivolumab for Patients with Myelofibrosis Resistant to JAK-inhibitor Treatment
GermanyStudy on Low-Dose Atropine Sulfate Eye Drops for Controlling Progressive Myopia in Caucasian Children
GermanyStudy on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
GermanyStudy of Pembrolizumab and Lenvatinib for Patients with Advanced Liver Cancer Resistant to Previous Immunotherapy
GermanyStudy on Guselkumab for Healing in Crohn's Disease Patients
GermanyStudy of AZD7798 compared to placebo in patients with moderate to severe Crohn's disease
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on plaque psoriasis and psoriatic arthritis, evaluating novel therapeutic approaches for both biologic-naive and experienced patients. Studies aim to assess treatment efficacy in reducing disease symptoms and improving patient outcomes.
Multiple investigations are comparing new therapeutic agents against placebo and established treatments.
Comprehensive studies addressing hidradenitis suppurativa and atopic dermatitis. Research focuses on evaluating new treatments for these challenging conditions, with emphasis on both immediate efficacy and long-term management.
Trials are examining both topical and systemic treatments for optimal disease control.
Innovative research addressing various skin conditions including chronic venous ulcers, actinic keratosis, and rosacea. Studies range from stem cell therapies for wound healing to novel topical treatments.
Research includes both traditional and cutting-edge therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
